IFN Alpha-2b
Showing 1 - 25 of >10,000
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 1, 2022
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 7, 2022
Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)
Recruiting
- Hepatitis B, Chronic
- PEGylated recombinant human interferon alpha-2b injection
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of Anhui Medical University
Jun 24, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Biopsy
- +7 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 23, 2023
Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,
Completed
- Metastatic Carcinoma in the Liver
- +4 more
- Celecoxib
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 25, 2022
Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)
Active, not recruiting
- Triple -Negative Breast Cancer
- +4 more
- Biopsy
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 1, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Suspended
- Anatomic Stage 0 Breast Cancer AJCC v8
- +18 more
- Celecoxib
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 4, 2022
Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma
Recruiting
- Stage III Hepatocellular Carcinoma AJCC v8
- +6 more
- Fluorouracil
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 18, 2021
Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)
Not yet recruiting
- Hepatitis B, Chronic
- hepalatide
- +3 more
-
Shanghai, Shanghai, ChinaShanghai Tong Ren Hospital
Nov 12, 2021
HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)
Unknown status
- HIV
- +2 more
- Pegylated Interferon alpha 2b (peg-IFN-α2b)
- 3BNC117 + 10-1074
-
Philadelphia, Pennsylvania
- +1 more
Jun 22, 2021
Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)
Active, not recruiting
- Hepatitis B, Chronic
- EYP001a
- +2 more
-
Hong Kong, Hong Kong
- +5 more
Sep 27, 2021
Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)
Not yet recruiting
- Chronic Hepatitis B
- PEG IFN α-2b; TAF
- (no location specified)
Aug 5, 2022
HPV Infection Trial (Human interferon alpha 2b vaginal Effervescent capsules)
Not yet recruiting
- HPV Infection
- Human interferon alpha 2b vaginal Effervescent capsules
- (no location specified)
May 8, 2023
Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors Trial in Pittsburgh (Chemokin Modulatory Regimen (5 MU/m2), Chemokin
Terminated
- Colorectal Cancer
- +3 more
- Chemokin Modulatory Regimen (5 MU/m2)
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Aug 21, 2020
Metastatic Renal Cell Carcinoma, RCC Trial in Philadelphia (Ixazomib, Pegylated IFN-alpha 2b)
Terminated
- Metastatic Renal Cell Carcinoma
- RCC
- Ixazomib
- Pegylated IFN-alpha 2b
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Sep 25, 2019
Malignant Pleural Mesothelioma Trial in Worldwide (rAd-IFN, Celecoxib Oral Product, Gemcitabine)
Active, not recruiting
- Malignant Pleural Mesothelioma
- rAd-IFN
- +2 more
-
Los Angeles, California
- +41 more
Oct 25, 2021
Malignant Tumor of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial
Completed
- Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface
- +2 more
- DC vaccine
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 6, 2020
Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)
Recruiting
- Cervical Dysplasia
- HPV Infection
- gel Interferon arm
- gel Interferon and interferon suppository arm
-
Ulaanbaatar, MongoliaNational Cancer Center
Nov 14, 2023
Lymphoma Trial in Houston (Fludarabine, Novantrone, Decadron)
Completed
- Lymphoma
- Fludarabine
- +14 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 22, 2020
Pancreas Cancer Trial (mRNA expression)
Not yet recruiting
- Pancreas Cancer
- mRNA expression
- (no location specified)
Aug 8, 2022
Hepatitis B Trial in New Delhi (Peg IFN 2b)
Unknown status
- Hepatitis B
- Peg IFN 2b
-
New Delhi, Delhi, IndiaInstitute of Liver and Biliary Sciences
Feb 1, 2020
Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before
Not yet recruiting
- Herpes Zoster
- Recombinant Human Interferon α-2b Gel (After the Alteration)
- Recombinant Human Interferon α-2b Gel (Before the Alteration)
- (no location specified)
Apr 7, 2023
Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)
Recruiting
- Adult T-cell Leukemia-Lymphoma
- ATLL
- Belinostat
- +3 more
-
Miami, FloridaUniversity of Miami
Jan 24, 2022